A degradatory fate for CCR4 suggests a primary role in Th2 inflammation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A degradatory fate for CCR4 suggests a primary role in Th2 inflammation
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 107, Issue 3, Pages 455-466
Publisher
Wiley
Online
2020-02-13
DOI
10.1002/jlb.2a0120-089rr
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
- (2016) Shigeo Fuji et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct CCR7 glycosylation pattern shapes receptor signaling and endocytosis to modulate chemotactic responses
- (2016) Mark A. Hauser et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting chemokine receptors in disease – a case study of CCR4
- (2015) Roberto Solari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
- (2015) Elna Van Der Ryst Frontiers in Immunology
- Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists
- (2014) Laura Ajram et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Gain-of-functionCCR4mutations in adult T cell leukemia/lymphoma
- (2014) Masao Nakagawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
- (2014) A. Meiser et al. JOURNAL OF IMMUNOLOGY
- Distinct Conformations of the Chemokine Receptor CCR4 with Implications for Its Targeting in Allergy
- (2014) J. M. Viney et al. JOURNAL OF IMMUNOLOGY
- Biased and G Protein-Independent Signaling of Chemokine Receptors
- (2014) Anne Steen et al. Frontiers in Immunology
- Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma
- (2013) Takashi Ishida et al. CANCER SCIENCE
- CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4
- (2013) Kandace Bonner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
- (2013) Anthony Cahn et al. BMC Pharmacology & Toxicology
- Chemokine Receptor Antagonists
- (2012) James Pease et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemokine Receptor 4 Plays a Key Role in T Cell Recruitment into the Airways of Asthmatic Patients
- (2010) P. Vijayanand et al. JOURNAL OF IMMUNOLOGY
- Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
- (2009) Peter J. McCormick et al. PLoS One
- Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells
- (2008) Geoffrey L Uy et al. EXPERT OPINION ON BIOLOGICAL THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now